Alcon Inc. (ALC)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 78.77 |
| Open | 79.21 |
| Bid | 0.00 x 1000 |
| Ask | 78.72 x 800 |
| Day's range | 78.59 - 79.52 |
| 52-week range | 69.44 - 88.23 |
| Volume | |
| Avg. volume | 910,872 |
| Market cap | 38.828B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 40.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.27 (0.35%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | N/A |
- Business Wire
Alcon Publishes Agenda for 2024 Annual General Meeting
GENEVA, April 07, 2024--Alcon Publishes Agenda for 2024 Annual General Meeting
- Business Wire
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
BENGALURU, India, March 12, 2024--The release will introduce Alcon's latest Intraocular Lens technology in India
- Business Wire
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
TORONTO, March 06, 2024--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’
© 2024 Yahoo. All rights reserved.